emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide fumarate · Medicine question

What minimum age and body weight are specified for adolescents receiving Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead for HIV-1 infection?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Adolescents receiving Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead for HIV-1 infection must be at least 12 years old and weigh at least 35 kg.

Sources for this answer

Emtricitabine/Rilpivirine/Tenofovir Alafenamide Gilead 200 mg/25 mg/25 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 24Document updated 22 October 2025

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about emtricitabine + rilpivirine hydrochloride + tenofovir alafenamide fumarate